◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Avanti Helium Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00 0.00
Cost Of Revenue 21,638 17,958 22,651 26,994 20,919
Gross Profit -21,638 -17,958 -22,651 -26,994 -20,919
Selling General And Administration 689,714 523,353 557,640 666,690 583,331
General And Administrative Expense 682,773 511,292 554,884 658,526 584,483
Other Operating Expenses 30,674 27,619 21,972 73,756 40,349
Operating Expense 720,388 550,972 579,612 740,446 623,680
Operating Income -742,026 -568,930 -602,263 -767,440 -644,599
EBIT -728,746 -477,131 -806,628 -1.7M -643,718
Interest Expense 10,923 10,775 5,159 17,139 8,941
Interest Expense Non Operating 10,923 10,775 5,159 17,139 8,941
Interest Income -- -- -- 0.00 0.00
Interest Income Non Operating -- -- -- 0.00 0.00
Net Interest Income -10,923 -10,775 -5,159 -17,139 -8,941
Other Income Expense 13,280 91,799 -204,365 -958,683 881.00
Special Income Charges 0.00 81,000 -178,834 -958,462 0.00
Gain On Sale Of Security 13,280 10,799 -25,531 -221.00 881.00
Pretax Income -739,669 -487,906 -811,787 -1.7M -652,659
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -739,669 -487,906 -811,787 -1.7M -652,659
Net Income From Continuing Operation Net Minority Interest -739,669 -487,906 -811,787 -1.7M -652,659
Net Income Including Noncontrolling Interests -739,669 -487,906 -811,787 -1.7M -652,659
Net Income Common Stockholders -739,669 -487,906 -811,787 -1.7M -652,659
Net Income -739,669 -487,906 -811,787 -1.7M -652,659
EBITDA -707,108 -459,173 -783,977 -1.7M -622,799
Normalized EBITDA -720,388 -550,972 -579,612 -740,446 -623,680
Reconciled Depreciation 21,638 17,958 22,651 26,994 20,919
Basic EPS -0.01 -0.00 -0.01 -- -0.01
Diluted EPS -0.01 -0.00 -0.01 -- -0.01
Basic Average Shares 114.0M 114.0M 110.2M -- 94.8M
Diluted Average Shares 114.0M 114.0M 110.2M -- 94.8M
Total Unusual Items 13,280 91,799 -204,365 -958,683 881.00
Total Unusual Items Excluding Goodwill 13,280 91,799 -204,365 -958,683 881.00
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00
Normalized Income -752,949 -579,705 -607,422 -784,579 -653,540
Diluted NI Availto Com Stockholders -739,669 -487,906 -811,787 -1.7M -652,659
Gain On Sale Of Ppe -- -- -- 0.00 0.00
Impairment Of Capital Assets 0.00 -81,000 178,834 958,462 0.00
Net Income Continuous Operations -739,669 -487,906 -811,787 -1.7M -652,659
Net Non Operating Interest Income Expense -10,923 -10,775 -5,159 -17,139 -8,941
Other Gand A 309,127 509,854 550,304 649,421 573,586
Reconciled Cost Of Revenue 21,638 17,958 22,651 26,994 20,919
Salaries And Wages 373,646 1,438 4,580 9,105 10,897
Selling And Marketing Expense 6,941 12,061 2,756 8,164 -1,152
Total Expenses 742,026 568,930 602,263 767,440 644,599
Total Operating Income As Reported -742,026 -- -- -- -644,599
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Cash And Cash Equivalents 865,183 83,505 343,740 105,652 172,386
Cash Cash Equivalents And Short Term Investments 961,183 83,505 343,740 105,652 172,386
Other Short Term Investments 96,000 -- -- -- --
Accounts Receivable 46,799 324,925 46,607 331,761 39,344
Receivables 46,799 324,925 46,607 331,761 39,344
Prepaid Assets 97,426 133,377 114,766 73,574 115,128
Current Assets 1.1M 541,807 505,113 510,987 326,858
Gross PPE 24.6M 25.5M 27.0M 27.1M 27.4M
Accumulated Depreciation -143,002 -128,470 -117,231 -100,472 -78,253
Net PPE 24.4M 25.4M 26.8M 27.0M 27.3M
Other Non Current Assets 62,547 62,547 62,547 62,547 62,547
Total Non Current Assets 24.5M 25.5M 26.9M 27.1M 27.4M
Total Assets 25.6M 26.0M 27.4M 27.6M 27.7M
Current Debt And Capital Lease Obligation 11,973 12,545 14,603 14,617 13,715
Payables And Accrued Expenses 2.1M 2.2M 2.0M 2.6M 1.7M
Current Liabilities 2.1M 2.3M 2.0M 2.6M 1.7M
Long Term Debt And Capital Lease Obligation 248,132 248,619 266,530 259,797 243,026
Long Term Capital Lease Obligation 248,132 248,619 266,530 259,797 243,026
Total Non Current Liabilities Net Minority Interest 481,723 487,414 512,097 499,749 462,691
Total Liabilities Net Minority Interest 2.6M 2.7M 2.5M 3.1M 2.2M
Common Stock 62.6M 61.6M 61.6M 60.3M 60.3M
Capital Stock 62.6M 61.6M 61.6M 60.3M 60.3M
Retained Earnings -51.7M -51.0M -50.4M -49.6M -47.8M
Gains Losses Not Affecting Retained Earnings 12.1M 12.6M 13.7M 13.5M 13.0M
Other Equity Adjustments 12.1M 12.6M 13.7M 13.5M 13.0M
Common Stock Equity 23.0M 23.3M 24.9M 24.5M 25.5M
Stockholders Equity 23.0M 23.3M 24.9M 24.5M 25.5M
Total Equity Gross Minority Interest 23.0M 23.3M 24.9M 24.5M 25.5M
Total Capitalization 23.0M 23.3M 24.9M 24.5M 25.5M
Net Tangible Assets 23.0M 23.3M 24.9M 24.5M 25.5M
Tangible Book Value 23.0M 23.3M 24.9M 24.5M 25.5M
Working Capital -1.0M -1.7M -1.5M -2.1M -1.4M
Invested Capital 23.0M 23.3M 24.9M 24.5M 25.5M
Total Debt 260,105 261,164 281,133 274,414 256,741
Share Issued 118.7M 114.0M 114.0M 96.8M 96.8M
Ordinary Shares Number 118.7M 114.0M 114.0M 96.8M 96.8M
Capital Lease Obligations 260,105 261,164 281,133 274,414 256,741
Current Capital Lease Obligation 11,973 12,545 14,603 14,617 13,715
Leases 129,610 129,610 129,370 129,610 129,610
Long Term Provisions 233,591 238,795 245,567 239,952 219,665
Machinery Furniture Equipment 4.1M 4.2M 4.5M 4.5M 4.2M
Other Equity Interest -- 71,400 -- 300,120 --
Other Properties 20.4M 21.2M 22.3M 22.5M 23.0M
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Operating Cash Flow -141,547 -699,638 -923,171 -298,366 -1.4M
Cash Flow From Continuing Operating Activities -141,547 -699,638 -923,171 -298,366 -1.4M
Depreciation And Amortization 21,638 17,958 22,651 26,994 20,919
Depreciation Amortization Depletion 21,638 17,958 22,651 26,994 20,919
Stock Based Compensation 373,646 1,438 4,580 9,105 10,897
Change In Working Capital 160,525 -48,669 -346,353 410,768 -837,418
Change In Receivables 278,126 -278,318 285,154 -292,417 11,238
Change In Payables And Accrued Expense -153,552 248,260 -590,315 661,631 -904,456
Other Non Cash Items 6,623 6,618 6,906 24,655 6,355
Capital Expenditure -- -12,748 -10,345 -61,554 -21,160
Purchase Of PPE -- -- 0.00 -46,032 --
Net PPE Purchase And Sale -81,518 381,000 0.00 -46,032 -218,814
Investing Cash Flow -86,270 368,252 -10,345 -61,554 451,410
Cash Flow From Continuing Investing Activities -86,270 368,252 -10,345 -61,554 451,410
Repayment Of Debt 164.00 -10,422 -6,913 -8,512 8,815
Net Issuance Payments Of Debt 164.00 -10,422 -6,913 -8,512 8,815
Issuance Of Capital Stock 1.1M 20,790 1.2M -103,904 945,281
Net Common Stock Issuance 1.1M 20,790 1.2M -103,904 945,281
Financing Cash Flow 1.0M 60,978 1.2M 291,559 954,096
Cash Flow From Continuing Financing Activities 1.0M 60,978 1.2M 291,559 954,096
Effect Of Exchange Rate Changes -27,723 10,173 123.00 1,627 -6.00
Changes In Cash 809,401 -270,408 237,965 -68,361 -39,503
Beginning Cash Position 83,505 343,740 105,652 172,386 211,895
End Cash Position 865,183 83,505 343,740 105,652 172,386
Free Cash Flow -131,817 -712,386 -933,516 -359,920 -1.5M
Asset Impairment Charge 0.00 -81,000 178,834 958,462 0.00
Capital Expenditure Reported 10,248 -12,748 -10,345 -15,522 670,224
Change In Prepaid Assets 35,951 -18,611 -41,192 41,554 55,800
Common Stock Issuance 1.1M 20,790 1.2M -103,904 945,281
Depreciation 21,638 17,958 22,651 26,994 20,919
Gain Loss On Sale Of PPE -- -- -- 0.00 0.00
Long Term Debt Payments 164.00 -10,422 -6,913 -8,512 8,815
Net Foreign Currency Exchange Gain Loss 35,690 7,789 21,998 14,912 6,897
Net Income From Continuing Operations -739,669 -603,772 -811,787 -1.7M -652,659
Net Long Term Debt Issuance 164.00 -10,422 -6,913 -8,512 8,815
Net Other Financing Charges -16,875 50,610 20,790 -- --
Net Other Investing Changes -- -- -10,345 -15,522 -29,454
Operating Gains Losses 35,690 7,789 21,998 14,912 6,897
Proceeds From Stock Option Exercised -- -- -- 0.00 --
Sale Of PPE -81,000 381,000 0.00 0.00 472,570
NEWS
Loading news...
TRENDING
Loading...